Discover 222 paid clinical trials in Albany, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 222
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Albany NY, New York NY, Summit NJ, Montreal, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Albany NY, New Haven CT, New York NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase 3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Albany NY, Poughkeepsie NY, Hartford CT, New Haven CT,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Albany NY, New Britain CT, Worcester MA, Burlington VT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Albany NY, New Windsor NY, The Bronx NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
for
Fibrostenotic Crohn's Disease
Location: Albany NY, Providence RI, Bradenton FL, Fort Worth TX,
Sponsor: Agomab Spain S.L.U.
Sex: All
Age: 18+
Code: NCT07683325
Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Two-Session Exposure Treatment and Parent Training for ARFID
for
Avoidant Restrictive Food Intake Disorder
Location: Albany NY
Sponsor: University at Albany
Sex: All
Age: 5 - 12
Code: NCT04913194
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
for
Primary Membranous Nephropathy
Location: Clifton Park NY, Indianapolis IN, Atlanta GA,
Sponsor: Climb Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07096843
Phase 2, Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
for
Proteinuric Kidney Diseases
Location: Clifton Park NY, Mineola NY, Bethlehem PA, Baltimore MD,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07355296
Phase 2, Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: Clifton Park NY, Mineola NY, East Providence RI,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07220083
Phase 3, Recruiting
Remote Temperature Monitoring of Patients At Risk for Developing Fever
for
Fever, Cancer, Remote Patient Monitoring
Location: Schenectady NY
Sponsor: AION Biosystems
Sex: All
Age: 18+
Code: NCT06752512
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Schenectady NY, White Plains NY, Boston MA, Montreal,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Schenectady NY, Hackensack NJ, New York NY, Summit NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Schenectady NY, Hawthorne NY, Boston MA, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation
for
Gait Rehabilitation
Location: Schenectady NY
Sponsor: University at Albany
Sex: All
Age: 18+
Code: NCT07043101
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission